|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.73 INR | -4.99% |
|
-4.99% | +4.47% |
| 05-28 | Fabino Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| 2023 | Fabino Life Sciences Limited Approves Executive Changes | CI |
Fabino Life Sciences Limited reported earnings results for the half year ended September 30, 2023. For the half year, the company reported sales was INR 128.61 million. Revenue was INR 120.72 million.
Net income was INR 0.88 million. Basic earnings per share from continuing operations was INR 0.42. Diluted earnings per share from continuing operations was INR 0.42.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.47% | 723K | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
FABINO LIFE SCIENCES LIMITED 
